A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States

References

• Ferguson E, Nelson L. Summary Minutes of the Joint Meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee of the U.S. Food and Drug Administration to Address the Public Health Problem of Liver Injury Related to the Use of Acetaminophen in Both Over-the-Counter and Prescription Products. Held June 29 and 30, 2009 at Adelphi, MD. Food and Drug Administration, Silver Spring, MD (2009). Available from: www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM179888.pdf [Last accessed on October 2013]
   Google Scholar
• Acetaminophen overdose. Medline Plus, a Service of the U.S. National Library of Medicine, National Institutes of Health, Bethesda, MD (2013). Available from: www.nlm.nih.gov/medlineplus/ency/article/002598.htm [Last accessed on October 2013]
   Google Scholar
• Mitka M. FDA asks physicians to stop prescribing high-dose acetaminophen products. JAMA 2014;311(6):563
   PubMedGoogle Scholar
• FDA FDA. Drug. Safety Communication: Prescription Acetaminophen Products to be Limited to 325 mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure. U.S. Food and Drug Administration, Silver Spring, MD (2011). Available from: www.fda.gov/drugs/drugsafety/ucm239821.htm [Last accessed on October 2013]
   Google Scholar
• FDA FDA recommends health care professionals discontinue prescribing and dispensing prescription combination drug products with more than 325 mg of acetaminophen to protect consumers. U.S. Food and Drug Administration, Silver Spring, MD (2014). Available from: www.fda.gov/Drugs/DrugSafety/ucm381644 [Last accessed on 4 March 2014]
   Google Scholar
• American Liver Foundation. The American Liver Foundation Issues Warning on Dangers of Excess Acetaminophen. American Liver Foundation, New York (2006). Available from: www.liverfoundation.org/downloads/alf_download_39.pdf [Last accessed on October 2013]
   Google Scholar
• AGS panel on pharmacological management of persistent pain in older persons. Pharmacological Management of Persistent Pain in Older Persons. American Geriatrics Society, New York (2009). Available from: www.americangeriatrics.org/files/documents/2009_Guideline.pdf [Last accessed on October 2013]
   Google Scholar
• CMS Announces Medicare Part D Overutilization Monitoring System (OMS) for Controlled Substances. Academy of Managed Care Pharmacy, Alexandria, VA (2013). Available from: www.amcp.org/uploadedFiles/Production_Menu/Policy_Issues_and_Advocacy/Letters,_Statements_and_Analysis_-_docs/2013/CMS_OMS_July2013_Letterhead_Final.pdf [Last accessed on October 2013]
   Google Scholar
• Lavonas EJ, Fries JF, Furst DE, et al. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf 2012;11(1):33-44
   PubMed Web of Science ®Google Scholar
• Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300(24):2867-78
   PubMed Web of Science ®Google Scholar
• Albertson TE, Walker VM Jr, Stebbins MR, et al. A population study of the frequency of high-dose acetaminophen prescribing and dispensing. Ann Pharmacother 2010;44(7-8):1191-5
   PubMedGoogle Scholar
• IMS Institute for Healthcare Informatics. The Use of Medicines in the United States: review of 2011. IMS Institute for Healthcare Informatics, Parsippany, NJ (2012). Availabe from www.environmentalhealthnews.org/ehs/news/2013/pdf-links/IHII_Medicines_in_U.S_Report_2011-1.pdf [Last accessed on October 2013]
   Google Scholar
• Duh MS, Vekeman F, Korves C, et al. Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications. Pain Med 2010;11(11):1718-25
   PubMedGoogle Scholar
• Mort JR, Shiyanbola OO, Ndehi LN, et al. Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization. Drug Saf 2011;34(11):1079-88
   PubMedGoogle Scholar
• Carey EJ, Vargas HE, Douglas DD, et al. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci 2008;53(7):1977-82
   PubMedGoogle Scholar
• Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology 2008;48(4):1336-41
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364-72
   PubMed Web of Science ®Google Scholar
• Ahmad SR, Elixhauser A, Sutton JP. Hepatotoxicity in Association with Acetaminophen Poisonings in the U.S. Abstract 588, Abstracts of the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Pharmacoepidemiol Drug Saf 2011;20:S256
   Google Scholar
• Budnitz DS, Lovegrove MC, Crosby AE. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med 2011;40(6):585-92
   PubMed Web of Science ®Google Scholar
• Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006;15(6):398-405
   PubMed Web of Science ®Google Scholar
• Michna E, Duh MS, Korves C, Dahl JL. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med 2010;11(3):369-78
   PubMed Web of Science ®Google Scholar
• Chang YJ, Nourjah P, Ahmad SR, Willy M. OSE Safety Review: Acetaminophen, hepatotoxicity, overdose and death. February 5, 2007. U.S. Food and Drug Administration, Office of Surveillance and Epidemiology, Silver Spring, MD (2007). Available from: www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164898.pdf [Last accessed on October 2013]
   Google Scholar
• Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007;102(11):2459-63
   PubMed Web of Science ®Google Scholar
• Kane A, Mitchell SJ, Carroll PR, et al. Characteristics of older and younger patients with suspected paracetamol toxicity. Australas J Ageing 2012;31(3):190-3
   PubMedGoogle Scholar
• Blackford MG, Felter T, Gothard MD, Reed MD. Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: a retrospective review. Clin Ther 2011;33(9):1322-30
   PubMedGoogle Scholar
• Martello JL, Pummer TL, Krenzelok EP. Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity. Clin Toxicol (Phila) 2010;48(1):79-83
   PubMed Web of Science ®Google Scholar
• Curhan SG, Eavey R, Shargorodsky J, Curhan GC. Analgesic use and the risk of hearing loss in men. Am J Med 2010;123(3):231-7
   PubMed Web of Science ®Google Scholar
• Curhan SG, Shargorodsky J, Eavey R, Curhan GC. Analgesic use and the risk of hearing loss in women. Am J Epidemiol 2012;176(6):544-54
   PubMedGoogle Scholar
• Ho T, Vrabec JT, Burton AW. Hydrocodone use and sensorineural hearing loss. Pain Physician 2007;10(3):467-72
   PubMedGoogle Scholar
• FDA FDA Warns of Rare Acetaminophen Risk. US Food and Drug Administration, SIlver Spring, MD (2013). www.fda.gov/ForConsumers/ConsumerUpdates/ucm363010.htm [Last accessed on October 2013]
   Google Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res 2001;3(2):98-101
   PubMedGoogle Scholar
• Miceli-Richard C, Le Bars M, Schmidely N, Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004;63(8):923-30
   PubMedGoogle Scholar
• Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum 2002;46(11):3046-54
   PubMed Web of Science ®Google Scholar
• Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006(1):CD004257
   PubMed Web of Science ®Google Scholar
• Gore M, Sadosky A, Leslie D, et al. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther 2011;33(12):1914-31
   PubMed Web of Science ®Google Scholar